H5N1 (Clade 2) Vaccination of Adults and Elderly

计划入组 517 人 · 首次发布于 2008 年 5 月 19 日

Safety and Immune Response to a Clade C DNA HIV Vaccine

计划入组 132 人 · 首次发布于 2016 年 12 月 20 日

Safety and Immunogenicity of Clade C ALVAC and gp120 HIV Vaccine

计划入组 132 人 · 首次发布于 2017 年 9 月 15 日

Clade C gp140

HIV clade B mRNA dendritic cell therapy (Immunomic Therapeutics/Universite Libre de Bruxelles)

II-559

Celgene International II SARL

Switzerland

Meiragtx UK II Ltd.

Belgium

Generics Bidco II, LLC

United States

Tonix Pharmaceuticals Identifies Three New Murine Models for Mpox, Reveals 2022 Clade IIb Is Up to 100,000-Fold Less Virulent Than 2003 Clade IIa

NIH Study Finds Siga's Tecovirimat Did Not Improve Mpox Resolution or Pain

WHO Declares Mpox a Global Health Emergency Amidst Rising Cases of More Virulent Strain